The Guardian
Email YouTube Facebook Instagram Twitter
 
News : World

Pfizer-BioNTech COVID-19 vaccine 95% effective in final trial

By DW
22 Nov 2020   |   2:52 pm   |  
Pfizer and BioNTec are preparing to submit their vaccine to US regulators for approval for emergency use. The two pharma firms claim the product is effective in 95% of the cases with no major safety concerns.


Share:

You may also like